SSA
GSK icon

Schonfeld Strategic Advisors’s GSK GSK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-360,000
Closed -$13.9M – 2183
2024
Q2 		$13.9M Buy
+360,000
New +$15.1M 0.09% 259

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Schonfeld Strategic Advisors's GSK Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in GSK (GSK) in Q2 2026: 199,265 shares worth $10.4M. The stake represents 0.04% of the portfolio and ranks #405 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in GSK as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in GSK in Q2 2016 and has held it in 27 quarters since. The position peaked at $75.7M in Q4 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Schonfeld Strategic Advisors held 199,265 shares of GSK worth $10.4M as of Q2 2026.
  • GSK was a new Schonfeld Strategic Advisors position in Q2 2026.
  • GSK made up 0.04% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #405 holding.
  • Schonfeld Strategic Advisors first reported a position in GSK in Q2 2016 and has held it in 27 quarters since.
  • Schonfeld Strategic Advisors's GSK position peaked at $75.7M in Q4 2024.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.